Goodwin
Dasol Lee
- Deals
- 5
- Latest
- Jun 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 5 deals
Often works with
- Dan Karelitz 3 deals together
- Arman Oruc 3 deals together
- Sarah Solomon 2 deals together
- Sarah Bock 2 deals together
- James Devendorf 2 deals together
- Jennifer Fay 2 deals together
- Danielle Fong 2 deals together
- Jackie Klosek 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | Topaz Labs | – | Adobe | Acquisition | Legal adviser to Topaz Labs (target) | Announced | – | AI | Adobe acquisition of Topaz Labs |
| Jun 2026 | Vendr | – | Vertice Technology | Acquisition | Legal adviser to Vendr (target) | Announced | – | SaaS+1 | Vertice Technology acquisition of Vendr |
| May 2026 | Perfuse Therapeutics | – | Bayer | Acquisition | Legal adviser to Perfuse Therapeutics (target) | Announced | 300.0 | Biotech+2 | Bayer acquisition of Perfuse Therapeutics |
| Apr 2026 | Kelonia Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Kelonia Therapeutics (target) | Announced | 7,000.0 | Biotech+2 | Eli Lilly and Company acquisition of Kelonia Therapeutics |
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
Deals where Dasol Lee is named on the firm's deal team, by the firm or the press.